Epidemiology and diagnosis of mucormycosis: an update

A Skiada, I Pavleas, M Drogari-Apiranthitou - Journal of fungi, 2020 - mdpi.com
Mucormycosis is an angioinvasive fungal infection, due to fungi of the order Mucorales. Its
incidence cannot be measured exactly, since there are few population-based studies, but …

Global epidemiology of mucormycosis

H Prakash, A Chakrabarti - Journal of Fungi, 2019 - mdpi.com
Mucormycosis is an angio-invasive fungal infection, associated with high morbidity and
mortality. A change in the epidemiology of mucormycosis has been observed in recent years …

[HTML][HTML] The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports

W Jeong, C Keighley, R Wolfe, WL Lee… - Clinical microbiology …, 2019 - Elsevier
Background The epidemiology of mucormycosis in the era of modern diagnostics is
relatively under-explored. Objectives To examine the contemporary epidemiology, clinical …

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the …

OA Cornely, A Alastruey-Izquierdo, D Arenz… - The Lancet infectious …, 2019 - thelancet.com
Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and …

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013

OA Cornely, S Arikan‐Akdagli… - Clinical Microbiology …, 2014 - Wiley Online Library
Abstract These European Society for Clinical Microbiology and Infectious Diseases and
European Confederation of Medical Mycology Joint Clinical Guidelines focus on the …

[HTML][HTML] A review on medicinally important heterocyclic compounds

T Qadir, A Amin, PK Sharma… - The Open …, 2022 - openmedicinalchemistryjournal.com
Heterocyclic compounds account for the most prominent and diverse class of organic
compounds. A significant number of heterocyclic compounds have been synthesized up to …

[HTML][HTML] Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on …

A Skiada, L Pagano, A Groll, S Zimmerli… - Clinical Microbiology …, 2011 - Elsevier
Zygomycosis is an important emerging fungal infection, associated with high morbidity and
mortality. The Working Group on Zygomycosis of the European Confederation of Medical …

Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis

G Chamilos, RE Lewis… - Clinical Infectious …, 2008 - academic.oup.com
Background. Zygomycosis is an emerging opportunistic mycosis among
immunocompromised patients with a particularly poor prognosis. Methods. We analyzed the …

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study

L Pagano, M Caira, A Candoni, M Offidani… - …, 2006 - haematologica.org
BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate the incidence and
outcome of invasive fungal infections (IFI) in patients with hematologic malignancies …

[HTML][HTML] Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in …

A Skiada, F Lanternier, AH Groll, L Pagano… - …, 2013 - ncbi.nlm.nih.gov
Mucormycosis is an emerging cause of infectious morbidity and mortality in patients with
hematologic malignancies. However, there are no recommendations to guide diagnosis and …